This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

I. Systemic Antimetabolites

HOWARD M. LEIBOWITZ, MD; JAMES H. ELLIOTT, MD

Arch Ophthalmol. 1966;75(6):826-835.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The surgical transplantation of a tissue from one member of a heterogeneous population to another member of the same species is known as an allograft or homograft; the same procedure performed across species lines is termed a xenograft or heterograft. Despite the technical feasibility of both such procedures, the more or less rapid destruction of the transplant is the ultimate outcome in the vast majority of attempts.

One apparent exception to this rule is transplantation of the cornea. In carefully selected cases, a high proportion of successful, transparent grafts are now being achieved. These clinical successes provide a striking contrast to the failures that generally accompany the transplantation of most other tissues.

Despite our present level of accomplishment in keratoplasty, the procedure has not attained a position of routine success. A significant number of even the most carefully selected cases end in failure in the hands of accomplished surgeons. More . . . [Full Text PDF of this Article]

Author Affiliations
Boston

From the Howe Laboratory of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston.

Footnotes
Submitted for publication Oct 7, 1965.

Reprint requests to 243 Charles St, Boston, Mass 02114 (Dr. Leibowitz).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?